Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 23, 2019Seminars in Cell and Developmental BiologyOpen Access

A CRISPR/Cas9 based polymeric nanoparticles to treat/inhibit microbial infections

View Full Paper
Ask AI
Bookmark
Share

Authors

RVRicha VermaRSRajnish SahuDSDesh Deepak Singh

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Verma et al. (2019) studied this question.

synapsesocial.com/papers/6a0da3e3cae7912d2fa52508https://doi.org/10.1016/j.semcdb.2019.04.007
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients2016 · 303 citations
  2. 2Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product1987 · 2,382 citations
  3. 3CRISPR/Cas9: Transcending the Reality of Genome Editing2017 · 87 citations
  4. 4Biodegradable PLGA85/15 nanoparticles as a delivery vehicle for<i>Chlamydia trachomatis</i>recombinant MOMP-187 peptide2012 · 48 citations
  5. 5SAHA (vorinostat) facilitates functional polymer-based gene transfection via upregulation of ROS and synergizes with TRAIL gene delivery for cancer therapy2018 · 20 citations